🇦🇺 Australia Country × Condition
solid tumor adult Clinical Trials in Australia
Active clinical trials for solid tumor adult with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 2, Phase 1 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇦🇺 Australia
Active Trials in Australia (4)
NCT06554795 Phase 1, Phase 2
Recruiting
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
Enrollment
360 pts
Country
🇦🇺 Australia
DualityBio Inc.
View Trial → NCT06625775 Phase 1
Recruiting
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Enrollment
392 pts
Country
🇦🇺 Australia
TheRas, Inc., d/b/a BBOT (BridgeBio...
View Trial → NCT06326411 Phase 1
Recruiting
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Enrollment
230 pts
Country
🇦🇺 Australia
Nested Therapeutics, Inc
View Trial → NCT04665206 Phase 1, Phase 2
Recruiting
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
Enrollment
434 pts
Country
🇦🇺 Australia
Vivace Therapeutics, Inc
View Trial → Frequently Asked Questions
How many solid tumor adult clinical trials are active in Australia?
There are currently 4 active clinical trials for solid tumor adult with sites in Australia, of which 4 are actively recruiting patients.
How can I join a solid tumor adult clinical trial in Australia?
To join a solid tumor adult clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are solid tumor adult trials in Australia?
Active solid tumor adult trials in Australia span Phase 1, Phase 2, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology